V Foundation awards top $80 million; vaccine in trial stage
Posted November 9, 2010
Cary, N.C. — The V Foundation for Cancer Research announced Tuesday that it has awarded $80 million to date in grants to 92 institutions.
The V Foundation awards 100 percent of all direct donations and net proceeds of events directly to cancer research and related programs.
"Our review board of over 20 leading physicians and scientists review every application, to determine where and how to most effectively find a cure," said CEO Nick Valvano, brother of North Carolina State University basketball coach Jim Valvano for whom the foundation is named.
"The V Vaccine," a product of research funded by the V Foundation at Moffitt Cancer Center in Tampa, Fla., will soon be in trials as a treatment to boost immunity in cancer patients.